-
-
Bio-tech & New Drugs Innotech Expo R&D of the first-in-class anti-diabetic drug, PS1
This invention is to apply PS1 to treatreverse T2D. The invention can be developed into small-molecule drugs. Those are first-in-class drugs for T2D because its novel anti-diabetic mode of action.
-
-
-
FutureTech Blowing type of Ketone gas sensor applied in healthy care
This technology is used micro-electro-mechanical systems combined nanomaterials and micro-heater systems, because the interdisciplinary integrated manufacturing technologies are used to make miniaturized sensor elements, which are equipped with bluetooth functions of algorithms and detection devices to monitor the ketones gas concentration during patient breathing applied in healthy care.
-
-
-
FutureTech 同步之心電圖與窄頻照明微循環影像系統
This work synchronizes electrocardiograph to narrow-band imaging with high-power lens to observe the micro-circulation on the skin. The time difference among the arrivals of the cardiac pulse wave on different parts of the path is then used to calculate the pulse wave velocity of the arteries, providing very helpful diagnosis of diseases closely related to the peripheral circulation.
-
-
-
Bio-tech & New Drugs FutureTech Peripheral Arterial Disease Screening System
In Taiwan, there are almost 96 million people look for medical treatment due to diabetes. The project successfully used the infrared light measurement system to observe the differences between the bilateral feet,collocating with the Chaos Synchronization to measure the differences between different signals, to decrease the probability of the attendance as the ultimate objective .
-
-
-
Precision Health Ecosystem FutureTech First-in-class anti-diabetic drug, PS1
Diabetes is now still an incurable disease. Beta cell failure is one of common causes. No drugs for this failure have been developed. This invention is to developapply PS1 to treatreverse diabetes. PS1 is a first-in-class small-molecule drug, which targets beta cells by improving their survivalfunction. As a result, PS1 can treatreverse diabetes. The anti-diabetic mechanism of
-
-
-
FutureTech 糖尿病症狀胰臟癌病患精準診斷平台
Monitoring PCDM-specific biomarkers, galectin-3S100A9, to serve as a risk assessment of pancreatic cancer on new-onset diabetes patients for early detection of PC.
-
-
-
Bio-tech & New Drugs FutureTech Develop of novel anti-diabetic agents via targeting endogenous lipid mediators
PPARγ is the master regulator of glucose metabolism.15-keto-PGE2 is an endogenous PPARγ ligand whitch is degraded by ZADH1. We found that increasing 15-keto-PGE2 promotes glucose uptake. We identified several ZADH1 inhibitors which could increase 15-keto-PGE2 promote glucose uptake via activating PPARγ. Our results showed that inhibition of ZADH1 is a novel approach to treat type 2 diabes mell
-
- 1
